Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Upcoming trial updates at SABCS 2020

Shane Stecklein • 9 Dec 2020
SABCS 2020
Breast Cancer
RxPONDER

Shane Stecklein, MD, PhD, University of Kansas Medical Center, Kansas City, KS, discusses upcoming trials at the San Antonio Breast Cancer Symposium (SABCS) 2020 virtual meeting, including the results of the RxPONDER trial, as well as how key updates can be translated to clinical practice. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Shane Stecklein

2:29
SWOG S9313: classification of TNBC by DNA damage response + homologous recombination deficiency
Shane Stecklein • 8 Dec 2020
0:54
Using biology to identify best outcomes
Shane Stecklein • 8 Dec 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals